Core Viewpoint - The company,拓新药业, is focused on research, production, and sales in the pharmaceutical and health sector, with a diversified business layout covering APIs, pharmaceutical intermediates, and functional food ingredients [1] Business Operations - The company has established a broad product line that serves key health areas such as antiviral, antitumor, and neurological medications, as well as functional foods [1] - The company’s subsidiary, 新乡制药, is producing and supplying the antiviral drug Ribavirin in a large-scale and stable manner to meet the public health demand during the flu season [1] Market Demand and Supply - Ribavirin is identified as a broad-spectrum and potent antiviral drug, serving as a key component in related antiviral medications [1] - The company has sufficient supply of APIs, which provides critical support for downstream formulation companies in producing flu treatment drugs, thereby alleviating market pressure during peak flu periods [1] Future Prospects - The company is actively pursuing the development of new antiviral drugs targeting influenza, aiming to address future market demands [1]

Core Viewpoint - The company, Tuoxin Pharmaceutical, is committed to research, production, and sales in the pharmaceutical and health sector, with a diversified business layout covering APIs, pharmaceutical intermediates, and functional food ingredients [1] Group 1: Business Operations - The company has established a wide product line that serves key health areas such as antiviral, antitumor, neurological medications, and functional foods [1] - Tuoxin Pharmaceutical's subsidiary, Xinxiang Pharmaceutical, is producing and supplying Ribavirin API in a large-scale and stable manner to meet the public health demand during the current flu outbreak [1] Group 2: Market Demand and Supply - Ribavirin is recognized as a broad-spectrum and potent antiviral drug, serving as a key component in related antiviral medications [1] - The sufficient supply of APIs from the company provides critical support for downstream formulation companies in producing flu treatment drugs, effectively addressing the medication demand during the flu peak [1] Group 3: Future Developments - The company is actively pursuing the development of new antiviral drugs targeting influenza, aiming to meet future market demands [1]

Core Viewpoint - The company, Tuoxin Pharmaceutical, emphasizes its strong position in the antiviral sector with a rich product portfolio and technological expertise in the development, production, and sales of pharmaceutical health products [1] Group 1: Company Overview - Tuoxin Pharmaceutical is identified as a high-tech enterprise focused on the research, development, production, and sales of pharmaceutical health products [1] - The company has a significant product reserve in the antiviral field, showcasing its capability and experience in this area [1] Group 2: Key Products - The core product, Ribavirin raw material, is highlighted as an important component of antiviral drugs and is classified as a broad-spectrum, potent antiviral medication [1] - Additionally, the company produces Cytidine and 5-Fluorouracil, which are key intermediates for synthesizing various antiviral drugs [1]